#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Eliot Davidowitz Email
Chief Scientific Officer, Co-Founder . Oligomerix
How to contact Eliot Davidowitz
Join and see Eliot's contact info for free!Current Roles
Employees:
13Revenue:
$2MAbout
Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for Alzheimer's disease and related dementias by targeting tau self-association. The company's drug discovery platform has identified a pipeline of novel small molecule inhibitors, with preclinical IND-enabling studies in progress for the lead program. Oligomerix's small molecule approach blocks the formation of all tau aggregates by targeting tau self-association, known as the beginning of the aggregation cascade, whereas other companies have focused on targeting large tau aggregates formed downstream. The NYC-based company is located at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine. Follow us on Twitter @oligomerixOligomerix Address
2 Westchester Park DriveWhite Plains, NY
United States